FEMY

Femasys Inc

Add to Watchlist

Advanced Chart

1.060

-0.010(-0.930%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

1.070

Open

1.060

VWAP

1.05

Vol

172.12K

Mkt Cap

28.87M

Low

1.0346

Amount

180.09K

EV/EBITDA(TTM)

Total Shares

22.22M

31.09M

EV/OCF(TTM)

P/S(TTM)

14.55

Femasys Inc. is a biomedical company. The Company is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

2.50M

+329.86%

1.70M

+206.36%

800.00K

+261.21%

Estimates Revision

The market is revising Downward the revenue expectations for Femasys Inc. (FEMY) for FY2025, with the revenue forecasts being adjusted by -16.1% over the past three months. During the same period, the stock price has changed by -32.91%.

Revenue Estimates for FY2025

Revise Downward

-16.1%

In Past 3 Month

Stock Price

Go Down

-32.91%

In Past 3 Month

2 Analyst Rating

749.06% Upside

Wall Street analysts forecast FEMY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FEMY is 9.00 USD with a low forecast of 3.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

749.06% Upside

Current: 1.060

Low

3.00

Averages

9.00

High

15.00

749.06% Upside

Current: 1.060

Low

3.00

Averages

9.00

High

15.00

Jones Trading

Catherine Novack

Strong Buy

Maintains

$10 → $6

2025-05-13

New

Reason

Jones Trading

Catherine Novack

Price Target

$10 → $6

2025-05-13

New

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Emily Bodnar

Strong Buy

Maintains

$15 → $12

2025-05-09

Reason

HC Wainwright & Co.

Emily Bodnar

Price Target

$15 → $12

2025-05-09

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Emily Bodnar

Strong Buy

Reiterates

$15

2025-03-28

Reason

HC Wainwright & Co.

Emily Bodnar

Price Target

$15

2025-03-28

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Emily Bodnar

Strong Buy

Maintains

$12 → $15

2025-03-19

Reason

HC Wainwright & Co.

Emily Bodnar

Price Target

$12 → $15

2025-03-19

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Emily Bodnar

Strong Buy

Reiterates

$12

2025-03-18

Reason

HC Wainwright & Co.

Emily Bodnar

Price Target

$12

2025-03-18

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Emily Bodnar

Strong Buy

Reiterates

$12

2025-03-13

Reason

HC Wainwright & Co.

Emily Bodnar

Price Target

$12

2025-03-13

Reiterates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Femasys Inc (FEMY.O) is -1.81, compared to its 5-year average forward P/E of -2.25. For a more detailed relative valuation and DCF analysis to assess Femasys Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-2.25

Current PE

-1.81

Overvalued PE

-0.53

Undervalued PE

-3.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

15.98

Current PS

3.65

Overvalued PS

35.36

Undervalued PS

-3.40

Financials

Annual

Quarterly

FY2025Q1

YoY :

+25.86%

341.26K

Total Revenue

FY2025Q1

YoY :

+57.70%

-5.46M

Operating Profit

FY2025Q1

YoY :

+64.06%

-5.91M

Net Income after Tax

FY2025Q1

YoY :

+35.29%

-0.23

EPS - Diluted

FY2025Q1

YoY :

+4.37%

-4.86M

Free Cash Flow

FY2025Q1

YoY :

-0.75%

40.77

Gross Profit Margin - %

FY2025Q1

YoY :

-5.75%

-1.21K

FCF Margin - %

FY2025Q1

YoY :

+30.16%

-1.73K

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

FEMY News & Events

Events Timeline

2025-03-27 (ET)

2025-03-27

09:03:21

Femasys reports FY24 EPS (85c), consensus (81c)

2025-03-19 (ET)

2025-03-19

09:23:53

Femasys enters partnership with CNY Fertility

2025-03-18 (ET)

2025-03-18

09:05:49

Femasys secures partnerships for commercialization of FemBloc in Spain

News

4.0

05-13Benzinga

Jones Trading Maintains Buy on Femasys, Lowers Price Target to $6

4.0

03-28Benzinga

HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $15 Price Target

4.0

03-19Benzinga

HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $15

People Also Watch

FAQ

What is Femasys Inc (FEMY) stock price today?

The current price of FEMY is 1.06 USD — it has decreased -0.93 % in the last trading day.

FEMY

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

FEMY News & Events

Events Timeline

News

People Also Watch

FAQ

What is Femasys Inc (FEMY) stock price today?

What is Femasys Inc (FEMY)'s business?

What is the price predicton of FEMY Stock?

What is Femasys Inc (FEMY)'s revenue for the last quarter?

What is Femasys Inc (FEMY)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Femasys Inc (FEMY)'s fundamentals?

How many employees does Femasys Inc (FEMY). have?

What is Femasys Inc (FEMY) market cap?